|
1
|
Esatbeyoglu T, Huebbe P, Ernst IM, Chin D,
Wagner AE and Rimbach G: Curcumin - from molecule to biological
function. Angew Chem Int Ed Engl. 51:5308–5332. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bauer AL, Jackson TL, Jiang Y and Rohlf T:
Receptor cross-talk in angiogenesis: mapping environmental cues to
cell phenotype using a stochastic, Boolean signaling network model.
J Theor Biol. 264:838–846. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jiang JT, Zhang LF, Zhou B, Zhang SQ, Li
SM, Zhang W, Zhang J, Qiao Z, Kong RR, Ma YF and Chen S:
Relationships of uPA and VEGF expression in esophageal cancer and
microvascular density with tumorous invasion and metastasis. Asian
Pac J Cancer Prev. 13:3379–3383. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sun P, Yu H, Zhang WQ, Hu M and Lv R:
Lentivirus-mediated siRNA targeting VEGF inhibits gastric cancer
growth in vivo. Oncol Rep. 28:1687–1692. 2012.PubMed/NCBI
|
|
5
|
Meng QW, Li Y, Hu BS, Shao PJ, Zhan MX, Yu
XY and Lu LG: Prognostic significance of serum level of vascular
endothelial growth factor receptor-2 in hepatocellular carcinoma
patients after transcatheter arterial chemoembolization. Zhonghua
Yi Xue Za Zhi. 93:341–4. 2013.(In Chinese). PubMed/NCBI
|
|
6
|
Zhao X, Li J, Zhuo J and Cai L:
Reexpression of ARHI inhibits tumor growth and angiogenesis and
impairs the mTOR/VEGF pathway in hepatocellular carcinoma. Biochem
Biophys Res Commun. 403:417–421. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang R, Zhao N, Li S, Fang JH, Chen MX,
Yang J, Jia WH, Yuan Y and Zhuang SM: MicroRNA-195 suppresses
angiogenesis and metastasis of hepatocellular carcinoma by
inhibiting the expression of VEGF, VAV2, and CDC42. Hepatology.
58:642–653. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Miuma S, Ichikawa T, Arima K, Takeshita S,
Muraoka T, Matsuzaki T, Ootani M, Shibata H, Akiyama M, Ozawa E, et
al: Branched-chain amino acid deficiency stabilizes insulin-induced
vascular endothelial growth factor mRNA in hepatocellular carcinoma
cells. J Cell Biochem. 113:3113–3121. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Brauer MJ, Zhuang G, Schmidt M, Yao J, Wu
X, Kaminker JS, Jurinka SS, Kolumam G, Chung AS, Jubb A, et al:
Identification and analysis of in vivo VEGF downstream markers link
VEGF pathway activity with efficacy of anti-VEGF therapies. Clin
Cancer Res. 19:3681–3692. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Inoue S, Hartman A, Branch CD, Bucana CD,
Bekele BN, Stephens LC, Chada S and Ramesh R: mda-7 in combination
with bevacizumab treatment produces a synergistic and complete
inhibitory affect on lung tumor xenograft. Mol Ther. 15:287–294.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hsu CH, Kang YK, Yang TS, Shun CT, Shao
YY, Su WC, Sandoval-Tan J, Chiou TJ, Jin K, Hsu C and Cheng AL:
Bevacizumab with erlotinib as first-line therapy in Asian patients
with advanced hepatocellular carcinoma: a multicenter phase II
study. Oncology. 85:44–52. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Futakuchi M, Hirose M, Ogiso T, Kato K,
Sano M, Ogawa K and Shirai T: Establishment of an in vivo highly
metastatic rat hepatocellular carcinoma model. Jpn J Cancer Res.
90:1196–1202. 1999. View Article : Google Scholar
|
|
13
|
Stroescu C, Dragnea A, Ivanov B, Pechianu
C, Herlea V, Sgarbura O, Popescu A and Popescu I: Expression of
p53, Bcl-2, VEGF, Ki67 and PCNA and prognostic significance in
hepatocellular carcinoma. J Gastrointestin Liver Dis. 17:411–417.
2008.PubMed/NCBI
|
|
14
|
Zhao K, Song X, Huang Y, Yao J, Zhou M, Li
Z, You Q, Guo Q and Lu N: Wogonin inhibits LPS-induced tumor
angiogenesis via suppressing PI3K/Akt/NF-κB signaling. Eur J
Pharmacol. 737:57–69. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yoshiji H, Kuriyama S, Yoshii J, Ikenaka
Y, Noguchi R, Yanase K, Namisaki T, Kitade M, Yamazaki M, Tsujinoue
H, et al: Involvement of the vascular endothelial growth factor
receptor-1 in murine hepatocellular carcinoma development. J
Hepatol. 41:97–103. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lee J, Choi KJ, Lim MJ, Hong F, Choi TG,
Tak E, Lee S, Kim YJ, Chang SG, Cho JM, et al: Proto-oncogenic
H-Ras, K-Ras, and N-Ras are involved in muscle differentiation via
phosphatidylinositol 3-kinase. Cell Res. 20:919–934. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lee JE, Cranna NJ, Chahal AS and Quinn LM:
Genetic systems to investigate regulation of oncogenes and tumour
suppressor genes in Drosophila. Cells. 1:1182–1196. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mateus AR, Simões-Correia J, Figueiredo J,
Heindl S, Alves CC, Suriano G, Luber B and Seruca R: E-cadherin
mutations and cell motility: a genotype-phenotype correlation. Exp
Cell Res. 315:1393–1402. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rak J and Yu JL: Oncogenes and tumor
angiogenesis: the question of vascular “supply” and vascular
“demand”. Semin Cancer Biol. 14:93–104. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cornellà H, Alsinet C and Villanueva A:
Molecular pathogenesis of hepatocellular carcinoma. Alcohol Clin
Exp Res. 35:821–825. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Heberlein A, Muschler M, Lenz B, Frieling
H, Büchl C, Gröschl M, Riera R, Kornhuber J, Bleich S and
Hillemacher T: Serum levels of vascular endothelial growth factor A
increase during alcohol withdrawal. Addict Biol. 15:362–364. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang JC, Teng CF, Wu HC, Tsai HW, Chuang
HC, Tsai TF, Hsu YH, Huang W, Wu LW and Su IJ: Enhanced expression
of vascular endothelial growth factor-A in ground glass hepatocytes
and its implication in hepatitis B virus hepatocarcinogenesis.
Hepatology. 49:1962–1971. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Aravalli RN, Steer CJ and Cressman EN:
Molecular mechanisms of hepatocellular carcinoma. Hepatology.
48:2047–2063. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Berasain C, Nicou A, Garcia-Irigoyen O,
Latasa MU, Urtasun R, Elizalde M, Salis F, Perugorría MJ, Prieto J,
Recio JA, Corrales FJ and Avila MA: Epidermal growth factor
receptor signaling in hepatocellular carcinoma: inflammatory
activation and a new intracellular regulatory mechanism. Dig Dis.
30:524–531. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Overmeyer JH and Maltese WA: Death
pathways triggered by activated Ras in cancer cells. Front Biosci
(Landmark Ed). 16:1693–1713. 2011. View
Article : Google Scholar
|
|
26
|
Ehrkamp A, Herrmann C, Stoll R and Heumann
R: Ras and rheb signaling in survival and cell death. Cancers
(Basel). 5:639–661. 2013. View Article : Google Scholar
|
|
27
|
Chen X, Lin YN, Fang DH, Zhang HQ and
Huang WJ: Effect of crucumin on vascular endothelial function in
atherosclerotic rabbits. Zhongguo Zhong Yao Za Zhi. 38:3343–3347.
2013.(In Chinese).
|
|
28
|
Ma J, Fang B, Zeng F, Pang H, Zhang J, Shi
Y, Wu X, Cheng L, Ma C, Xia J and Wang Z: Curcumin inhibits cell
growth and invasion through up-regulation of miR-7 in pancreatic
cancer cells. Toxicol Lett. 231:82–91. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Almanaa TN, Geusz ME and Jamasbi RJ: A new
method for identifying stem-like cells in esophageal cancer cell
lines. J Cancer. 4:536–548. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Johnson JJ and Mukhtar H: Curcumin for
chemoprevention of colon cancer. Cancer Lett. 255:170–181. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen WC, Lai YA, Lin YC, Ma JW, Huang LF,
Yang NS, Ho CT, Kuo SC and Way TD: Curcumin suppresses
doxorubicin-induced epithelial-mesenchymal transition via the
inhibition of TGF-β and PI3K/AKT signaling pathways in
triple-negative breast cancer cells. J Agric Food Chem.
61:11817–11824. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sun ZJ, Chen G, Zhang W, Hu X, Liu Y, Zhou
Q, Zhu LX and Zhao YF: Curcumin dually inhibits both mammalian
target of rapamycin and nuclear factor-κB pathways through a
crossed phosphatidylinositol 3-kinase/Akt/IκB kinase complex
signaling axis in adenoid cystic carcinoma. Mol Pharmacol.
79:106–118. 2011. View Article : Google Scholar
|
|
33
|
Pantazis P, Varman A, Simpson-Durand C,
Thorpe J, Ramalingam S, Subramaniam D, Houchen C, Ihnat M, Anant S
and Ramanujam RP: Curcumin and turmeric attenuate arsenic-induced
angiogenesis in ovo. Altern Ther Health Med. 16:12–14.
2010.PubMed/NCBI
|
|
34
|
Wang M, Ruan Y, Chen Q, Li S, Wang Q and
Cai J: Curcumin induced HepG2 cell apoptosis-associated
mitochondrial membrane potential and intracellular free Ca(2+)
concentration. Eur J Pharmacol. 650:41–47. 2011. View Article : Google Scholar
|
|
35
|
Ranjan AP, Mukerjee A, Helson L, Gupta R
and Vishwanatha JK: Efficacy of liposomal curcumin in a human
pancreatic tumor xenograft model: inhibition of tumor growth and
angiogenesis. Anticancer Res. 33:3603–3609. 2013.PubMed/NCBI
|
